Hospira Recalls Diazepam Injection Vials Due to Sterility Concerns
Hospira Inc. is recalling 72,300 vials of Diazepam Injection due to ineffective crimps that may compromise sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving potential sterility issues in injectable medications.
Plain-English summary
Hospira Inc. is recalling 72,300 vials of Diazepam Injection, USP, 5 mg/mL, 10 mL, Multiple-dose Sterile Non-pyrogenic, Fliptop Vial. The product is identified by NDC 0409-3213-12, Lot 23-505-EV, with an expiration date of 11/14.
The recall was initiated due to a lack of assurance of sterility. The source text indicates that ineffective crimps on the fliptop vials may result in leaking at the neck of the vials, which poses a risk to the sterility of the medication.
The affected product was distributed nationwide and in Puerto Rico. Consumers and healthcare providers should stop using the recalled vials and contact their pharmacist or healthcare provider for a replacement or further instructions.
The recalled product
- Product
- DIAZEPAM (DIAZEPAM)
- Brand
- DIAZEPAM
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injectable
- Affected units
- 72,300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 23-505-EV
- Exp. 11/14
Distribution
Related recalls
Same brand · DIAZEPAM
- LowValeant Recalls Diazepam Rectal Gel Due to Missing Lot and Expiration Dates
FDA (Drugs) · 2018-08-15
- SevereHospira Recalls Diazepam Injection Due to Crystallized Active Ingredient
FDA (Drugs) · 2016-07-20
- SevereHospira Recalls Diazepam Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2013-06-12
- SevereHospira Recalls Diazepam Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-15
- SevereHospira Recalls Diazepam Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2013-05-08
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29